Publication | Closed Access

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)

Surgical OncologyGastrointestinal OncologyRecurrent Gastric CancerCombined ChemotherapyMedicinePathologyKdog 0601Cancer TreatmentOncologyRadiation OncologyCancer Research